Circulating fatty acids and prostate cancer risk: Individual participant meta-analysis of prospective studies

Journal of the National Cancer Institute

Volumn 106, Issue 9, 2014, Pages

  Crowe, Francesca L ^a   Appleby, Paul N ^a   Travis, Ruth C ^a   Barnett, Matt ^b   Brasky, Theodore M ^c   Bueno De mesquita, H Bas ^d,e,f   Chajes, Veronique ^g   Chavarro, Jorge E ^h,i   Chirlaque, Maria Dolores ^j,k   English, Dallas R ^l,m   Gibson, Robert A ⁿ   Giles, Graham G ^l,m   Goodman, Gary E ^b   Henning, Susanne M ^o   Kaaks, Rudolf ^p   King, Irena B ^b,q   Kolonel, Lawrence N ^r   Kristal, Alan R ^b   Neuhouser, Marian L ^b   Park, Song Yi ^a   Severi, Gianluca ^l,m   Siddiq, Afshan ^f   Stampfer, Meir J ^h,i   Stattin, Pär ^s   Tangen, Catherine M ^b   Tjønneland, Anne ^t   Trichopoulos, Dimitrios ^u,v,w   Tumino, Rosario ^x   Wilkens, Lynne R ^r   Key, Timothy J ^a   Allen, Naomi E ^a   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b USA   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h CHANNING LABORATORY   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Murcia Regional Health Authority   (Spain)

^k CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^l CANCER EPIDEMIOLOGY CENTRE   (Australia)

^m UNIVERSITY OF MELBOURNE   (Australia)

ⁿ UNIVERSITY OF ADELAIDE   (Australia)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^s UMEÅ UNIVERSITY   (Sweden)

^t DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^u HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^v BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^w HELLENIC HEALTH FOUNDATION   (Greece)

^x CIVILE M P AREZZO HOSPITAL   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; STEARIC ACID; STEARIC ACID DERIVATIVE; UNSATURATED FATTY ACID;

BIBLIOGRAPHIC DATABASE; CANCER GRADING; CANCER PATIENT; CANCER RISK; CANCERLIT; CASE CONTROL STUDY; COCHRANE LIBRARY; DISEASE ASSOCIATION; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MEDLINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; WEB OF SCIENCE; AGED; BLOOD; META ANALYSIS; MIDDLE AGED; PROSTATE TUMOR; RISK; RISK FACTOR; STATISTICAL MODEL;

AGED; CASE-CONTROL STUDIES; EICOSAPENTAENOIC ACID; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS; STEARIC ACIDS;

EID: 84928590183     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju240     Document Type: Review

References (33)

1. Howell MA. Factor analysis of international cancer mortality data and per capita food consumption. Br J Cancer. 1974;29(4):328-336.
2. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15(4):617-631.
3. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol. 2005;23(32):8152-8160.
4. Arab L. Biomarkers of fat and fatty acid intake. J Nutr. 2003;133(suppl 3):925S-932S.
5. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47(5):348-380.
6. Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L. Prediagnostic level of fatty acids in serum phospholipids: Ω-3 and Ω-6 fatty acids and the risk of prostate cancer. Int J Cancer. 1997;71(4):545-551.
7. Mannisto S, Pietinen P, Virtanen MJ, et al. Fatty Acids and Risk of Prostate Cancer in a Nested Case-Control Study in Male Smokers. Cancer Epidemiol Biomarkers Prev. 2003;12(12):1422-1428.
8. Laaksonen DE, Laukkanen JA, Niskanen L, et al. Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: A population-based cohort study. Int J Cancer. 2004;111(3):444-450.
9. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A Prospective Study of Polyunsaturated Fatty Acid Levels in Blood and Prostate Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1364-1370.
10. Crowe FL, Allen NE, Appleby PN, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr. 2008;88(5):1353-1363.
11. Park S, Wilkens LR, Henning SM, et al. Circulating fatty acids and prostate cancer risk in a nested case-control study: The Multiethnic Cohort. Cancer Causes Control. 2009;20(2):211-223.
12. Brasky TM, Till C, White E, et al. Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial. Am J Epidemiol. 2011;173(12):1429-1439.
13. Bassett JK, Severi G, Hodge AM, et al. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. Int J Cancer. 2013;133(8):1882-1891.
14. Brasky TM, Darke AK, Song X, et al. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial. J Natl Cancer Inst. 2013;105(15):1132-1141.
15. Cheng TY, King IB, Barnett MJ, et al. Serum phospholipid fatty acids, genetic variation in myeloperoxidase, and prostate cancer risk in heavy smokers: a gene-nutrient interaction in the carotene and retinol efficacy trial. Am J Epidemiol. 2013;177(10):1106-1117.
16. Roddam AW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies. J Natl Cancer Inst. 2008;100(3):170-183.
17. Gleason DF. Histologic grade, clinical stage, and patient age in prostate cancer. NCI Monogr. 1988;(7):15-18.
18. Key TJ, Appleby PN, Allen NE, Reeves GK. Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones. Cancer Epidemiol Biomarkers Prev. 2010;19(4):960-965.
19. Lichtenstein AH, Erkkila AT, Lamarche B, Schwab US, Jalbert SM, Ausman LM. Influence of hydrogenated fat and butter on CVD risk factors: Remnant-like particles, glucose and insulin, blood pressure and C-reactive protein. Atherosclerosis. 2003; (1) 171:97-107.
20. Tholstrup T, Raff M, Basu S, Nonboe P, Sejrsen K, Straarup EM. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am J Clin Nutr. 2006;83(2):237-243.
21. Vega-López S, Ausman LM, Jalbert SM, Erkkila AT, Lichtenstein AH. Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr. 2006;84: (1) 54-62.
22. Sun Q, Ma J, Campos H, Hankinson SE, Hu FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr. 2007;86(1):74-81.
23. Hvan Dam RM and Hunter D. Biochemical indicators of dietary intake. In: Willett W, ed. Nutritional Epidemiology. Oxford: Oxford University Press, 2012:150-212.
24. Hodson L, Fielding BA. Stearoyl-CoA desaturase: Rogue or innocent bystander? Prog Lipid Res. 2013;52(1):15-42.
25. Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol. 1998;148(8):775-785.
26. D'Ambrosio G, Samani F, Cancian M, De Mola C. Practice of opportunistic prostate-specific antigen screening in Italy: Data from the Health Search database. Eur J Cancer Prev. 2004;13(5):383-386.
27. Jonsson H, Holmstrom B, Duffy SW, Stattin P. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. Int J Cancer. 2011;129(8):1881-1888.
28. Williams N, Hughes LJ, Turner EL, et al. Prostate-specific antigen testing rates remain low in UK general practice: A cross-sectional study in six English cities. BJU Int. 2011;108(9):1402-1408.
29. Chavarro JE, Stampfer MJ, Hall MN, Sesso HD, Ma J. A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality Am J Clin Nutr. 2008;88(5):1297-1303.
30. Gann PH, Hennekens CH, Sacks FM, Grodstein F, Giovannucci EL, Stampfer MJ. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst. 1994;86(4):281-286.
31. Simon JA, Chen Y, Bent S. The relation of a-linolenic acid to the risk of prostate cancer: A systematic review and meta-analysis. Am J Clin Nutr. 2009;89(5):1558S-1564S.
32. Patel MI, Kurek C, Dong Q. The Arachidonic Acid Pathway and its Role in Prostate Cancer Development and Progression. J Urol. 2008;179(5):1668-1675.
33. Ma J, Folsom AR, Eckfeldt JH, et al. Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters. Am J Clin Nutr. 1995;62(3):572-578.